Soligenix Balance Sheet Health
Financial Health criteria checks 5/6
Soligenix has a total shareholder equity of $4.2M and total debt of $2.9M, which brings its debt-to-equity ratio to 69.1%. Its total assets and total liabilities are $11.3M and $7.1M respectively.
Key information
69.1%
Debt to equity ratio
US$2.92m
Debt
Interest coverage ratio | n/a |
Cash | US$10.30m |
Equity | US$4.22m |
Total liabilities | US$7.08m |
Total assets | US$11.30m |
Recent financial health updates
Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?
Sep 06Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?
Apr 22Is Soligenix (NASDAQ:SNGX) Using Too Much Debt?
Jan 03Recent updates
Soligenix: A Biotech Bargain Ready To File For Approval In Cutaneous T-Cell Lymphoma
Oct 05U.S. FDA awards $2.6M grant for expanded study of Soligenix's HyBryte for skin cancer
Sep 12Soligenix announces $2.6M FDA grant to further study blood cancer candidate
Sep 06Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?
Sep 06Soligenix GAAP EPS of -$0.06 beats by $0.03, revenue of $0.4M beats by $0.2M
Aug 12Soligenix, SERB Pharma team up to develop therapy for ricin poisoning
Jul 25Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?
Apr 22Is Soligenix (NASDAQ:SNGX) Using Too Much Debt?
Jan 03Shareholders May Find It Hard To Justify Increasing Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation For Now
Sep 17Health Check: How Prudently Does Soligenix (NASDAQ:SNGX) Use Debt?
Aug 30Is Soligenix (NASDAQ:SNGX) Weighed On By Its Debt Load?
May 08What Type Of Returns Would Soligenix's(NASDAQ:SNGX) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Mar 16Soligenix inks supply and distribution deal for SGX301 companion light device in cancer
Jan 07Soligenix receives $1.5M grant advancing COVID-19 vaccine development
Dec 28Soligenix's SGX942 flunks oral mucositis study in cancer patients, shares plummet 44%
Dec 22Soligenix announces $20M strategic convertible debt financing agreement
Dec 16Why Soligenix's (NASDAQ:SNGX) CEO Pay Matters
Nov 20Financial Position Analysis
Short Term Liabilities: SNGX's short term assets ($11.0M) exceed its short term liabilities ($5.5M).
Long Term Liabilities: SNGX's short term assets ($11.0M) exceed its long term liabilities ($1.6M).
Debt to Equity History and Analysis
Debt Level: SNGX has more cash than its total debt.
Reducing Debt: SNGX's debt to equity ratio has increased from 0% to 69.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SNGX has sufficient cash runway for 12 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: SNGX is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.